7
Management of Giant Retinal Tears without Scleral Buckling Use of Radical Dissection of the Vitreous Base and Per/luoro--octane and Intraocular Tamponade Allan E. Kreiger, MD, Hilel Lewis, MD T he introduction of intraoperative perfluorocarbon liquids in the management of giant retinal tears has allowed exact anatomic reapposition of the retina and the giant retinal tear. Therefore, the authors managed 11 eyes with giant retinal tears and no proliferative vitreoretinopathy without scleral buckling. Maximum removal of the basal vitreous gel was performed in all cases, and perfluoro-octane was used intraoperatively to unfold the inverted posterior flap and reattach the retina completely. Endophotocoag- ulation was applied to the edges of the tear and perfluoropropane or silicone oil was used as an intraocular tamponade. Although 1 eye required reoperation for a redetach- ment from posterior proliferative vitreoretinopathy, all retinas were reattached with final visual acuity of 5/200 or better in 9 eyes. Eight additional major procedures were nec- essary in seven eyes: removal of silicone oil in four (with removal of peri silicone prolif- eration in three), repeat vitrectomy and membrane removal with photocoagulation twice in one eye, cataract extraction in one eye, and removal of a macular pucker in one eye. Four eyes required postoperative fluid-gas exchange and three eyes had tissue plas- minogen activator injections into the anterior chamber for postoperative fibrin reactions. Ophthalmology 1992;99:491-497 Anatomic and visual results of repair of retinal detach- ment from giant retinal tears have steadily improved since the development of vitreous surgery. 1 Modem surgical techniques have resulted in better intraoperative man- agement of the retina and the giant retinal tear so that closure of the break at the end of the procedure is assured. Perfluorocarbon liquids have been shown to greatly fa- cilitate this goal. 2 The problem of recurrent detachment, however, continues to be vexing. A number of factors contribute to redetachment, including extension of the giant tear, formation of new retinal breaks, or reopening of tears from proliferative vitreoretinopathy (PVR). Tra- ditionally, scleral buckling has been used in an attempt to minimize such complications. Originally received: October 13, 1991. Revision accepted: December 5, 1991. From the Department of Ophthalmology, UCLA School of Medicine, Jules Stein Eye Institute, Los Angeles. Presented at the American Academy of Ophthalmology Annual Meeting, Anaheim, October 1991. Reprint requests to Allan E. Kreiger, MD, Jules Stein Eye Institute, UCLA Medical Center, 100 Stein Plaza, Los Angeles, CA 90024-7007. Scleral buckles are believed to reduce early and late traction within the vitreous base. Thus, they insure that the giant retinal tear will remain closed and will not ex- tend, and they decrease the likelihood of recurrent retinal detachment due to the formation of new anterior retinal breaks. 1,3-10 Conversely, scleral buckling procedures have been suspected to complicate the closure of giant retinal tears because of their distortion of the shape of the eye, their tendency to exacerbate "slippage" of the retina pos- teriorly, and the possibility that the additional trauma they cause might lead to PVR. 2 ,11,12 It is also plausible 491

Management of Giant Retinal Tears without Scleral Buckling

  • Upload
    hilel

  • View
    212

  • Download
    0

Embed Size (px)

Citation preview

Management of Giant Retinal Tears without Scleral Buckling Use of Radical Dissection of the Vitreous Base and Per/luoro--octane and Intraocular Tamponade

Allan E. Kreiger, MD, Hilel Lewis, MD

The introduction of intraoperative perfluorocarbon liquids in the management of giant retinal tears has allowed exact anatomic reapposition of the retina and the giant

retinal tear. Therefore, the authors managed 11 eyes with giant retinal tears and no proliferative vitreoretinopathy without scleral buckling. Maximum removal of the basal vitreous gel was performed in all cases, and perfluoro-octane was used intraoperatively to unfold the inverted posterior flap and reattach the retina completely. Endophotocoag­ulation was applied to the edges of the tear and perfluoropropane or silicone oil was used as an intraocular tamponade. Although 1 eye required reoperation for a redetach­ment from posterior proliferative vitreoretinopathy, all retinas were reattached with final visual acuity of 5/200 or better in 9 eyes. Eight additional major procedures were nec­essary in seven eyes: removal of silicone oil in four (with removal of peri silicone prolif­eration in three), repeat vitrectomy and membrane removal with photocoagulation twice in one eye, cataract extraction in one eye, and removal of a macular pucker in one eye. Four eyes required postoperative fluid-gas exchange and three eyes had tissue plas­minogen activator injections into the anterior chamber for postoperative fibrin reactions. Ophthalmology 1992;99:491-497

Anatomic and visual results of repair of retinal detach­ment from giant retinal tears have steadily improved since the development of vitreous surgery. 1 Modem surgical techniques have resulted in better intraoperative man­agement of the retina and the giant retinal tear so that closure of the break at the end of the procedure is assured. Perfluorocarbon liquids have been shown to greatly fa­cilitate this goal.2 The problem of recurrent detachment,

however, continues to be vexing. A number of factors contribute to redetachment, including extension of the giant tear, formation of new retinal breaks, or reopening of tears from proliferative vitreoretinopathy (PVR). Tra­ditionally, scleral buckling has been used in an attempt to minimize such complications.

Originally received: October 13, 1991. Revision accepted: December 5, 1991.

From the Department of Ophthalmology, UCLA School of Medicine, Jules Stein Eye Institute, Los Angeles.

Presented at the American Academy of Ophthalmology Annual Meeting, Anaheim, October 1991.

Reprint requests to Allan E. Kreiger, MD, Jules Stein Eye Institute, UCLA Medical Center, 100 Stein Plaza, Los Angeles, CA 90024-7007.

Scleral buckles are believed to reduce early and late traction within the vitreous base. Thus, they insure that the giant retinal tear will remain closed and will not ex­tend, and they decrease the likelihood of recurrent retinal detachment due to the formation of new anterior retinal breaks. 1,3-10 Conversely, scleral buckling procedures have been suspected to complicate the closure of giant retinal tears because of their distortion of the shape of the eye, their tendency to exacerbate "slippage" of the retina pos­teriorly, and the possibility that the additional trauma they cause might lead to PVR.2,11,12 It is also plausible

491

..r:..

Tab

le 1

. Cli

nica

l D

etai

ls o

f P

atie

nts

\0

N

Pat

ien

t N

o.!

A

ssoc

iate

d A

ge (

yrs)

/ O

cula

r G

ian

t R

etin

al

Pre

op

erat

ive

Po

sto

per

ativ

e F

ollo

w-u

p S

ex

Eye

C

ondi

tion

s P

revi

ous

Sur

gery

T

ear

Size

O

per

atio

n

Add

itio

nal S

urge

ry

Com

plic

atio

ns

Vis

ual A

cuit

y

Vis

ual

Acu

ity

(m

os)

1/21

/M

OD

P

enet

rati

ng

CE

+ P

C 1

0L

2

GR

T

PP

V +

PF

C +

lase

r +

R

emov

al o

f S

IO (4

mos

) N

one

20/2

5 20

/20

7 tr

aum

a (a

ge 2

0)

180

0 P

FC

/SIO

(a

ge 2

0)

900

2/3

1/M

O

D

Blu

nt t

raum

a C

E (a

ge 2

3)

180

0 P

PV

+ u

nfol

d +

PF

C

P /C

, R

emov

al o

f S

IO

Mild

inc

reas

e H

M

HM

16

(a

ge 5

) at

tem

pted

rep

air

2 R

adia

l +

lase

r +

PF

C/S

IO

rem

ove

mem

bran

e lO

P

ofG

RT

(1 d

ay

exte

nsio

ns

pri

orV

X a

nd

Ret

inal

sm

all

gas

adhe

renc

e bu

bble

)

3/5

3/F

O

D

Myo

pia

Non

e 12

00

PP

V +

PF

C +

lase

r +

F

luid

-gas

exc

hang

e N

one

20/6

0 20

/100

29

2

Rad

ial

PF

C/g

as e

xcha

nge

CE

+ P

C 1

0L

ex

tens

ions

(1

6 m

os)

4/1

6/F

O

D

Myo

pia,

N

one

360

0 PP

L +

PP

V +

PF

C +

T

-PA

+ fl

uid-

gas

Fib

rin

reac

tion

L

P 20

/200

18

vi

treo

us

lase

r +

PF

C/g

as

exch

ange

ch

ange

s ex

chan

ge

Mac

puc

ker

(7 m

os)

5/9

/M

OS

M

yopi

a,

Non

e 36

00

PPL

+ P

PV

+ P

FC

+

PP

V +

MS

+ la

ser

PV

R

LP

LP

19

vitr

eous

la

ser

+ P

FC

/SIO

(6

wks

) ch

ange

s P

PV

+ M

S +

lase

r P

VR

(5

mos

) H

ypot

ony

6/14

/F

OS

M

yopi

a,

Non

e 36

00

PPL

+ P

PV

+ P

FC

+

TP

A

Fib

rin

reac

tion

H

M

3/20

0 18

vi

treo

us

lase

r +

PF

C/S

IO

Rem

oval

of S

IO +

PS

P +

ch

ange

s di

ssec

tion

of

PSP

+

Hyp

oton

y ep

icili

ary

prol

ifer

atio

n (3

mos

)

7/52

/M

OD

N

one

CE

+ P

C 1

0L

33

00

Rem

oval

of

SB +

F

luid

-gas

exc

hang

e N

one

HM

20

/60

7 at

tem

pted

rep

air

PP

V +

PF

C +

o

fGR

Tw

ith

P

FC

/gas

exc

hang

e pl

acem

ent o

f +

lase

r hi

ghS

B

8/4

3/M

O

S

Blu

nt tr

aum

a,

CE

+ P

C I

OL

12

00 P

PV

+ P

FC

+

Non

e N

one

HM

20

/30

8 hi

gh m

yopi

a at

tem

pted

rep

air

PF

C/g

as e

xcha

nge

ofG

RT

by

+ la

ser

pneu

mat

ic

reti

nope

xy

9/65

/F

OS

N

one

CE

+ A

C I

OL

30

00

Iris

sut

ures

+ P

PV

+

TP

A +

flui

d-ga

s F

ibri

n re

acti

on

LP

1/20

0 7

PF

C +

PF

C/g

as

exch

ange

ex

chan

ge +

lase

r

1O/1

0/F

O

D

Hig

h m

yopi

a N

one

1800

PP

V +

PF

C +

lase

r +

R

emov

al o

f SIO

E

mul

sifi

catio

n C

F

20/5

0 9

PF

C/f

luid

+ fl

uid

(6w

ks)

ofS

IO

SIO

11/6

7/M

O

S

Non

e N

one

110

0 P

PV

+ P

FC

+ la

ser +

N

one

Non

e 20

/300

20

/40

9 1

Rad

ial

PF

C/f

luid

+ fl

uid-

exte

nsio

n ga

s ex

chan

ge

OD

= ri

ght e

ye; C

E =

cat

arac

t ext

ract

ion;

PC

10

L =

pos

teri

or c

ham

ber i

ntra

ocul

ar le

ns; G

R T

= g

iant

ret

inal

tear

; PP

V =

par

s pl

ana

vitr

ecto

my;

PF

C =

per

fluo

roca

rbon

liqu

id; P

FC

/SIO

= p

erfl

uoro

carb

on

liqu

id/s

ilic

one

oil e

xcha

nge;

SIO

= s

ilico

ne o

il; V

X =

vit

rect

omy;

P /C

= p

hoto

coag

ulat

ion;

lO

P =

intr

aocu

lar p

ress

ure;

HM

= h

and

mot

ions

; PF

C/g

as e

xcha

nge

= p

erfl

uoro

carb

on li

quid

/per

fluo

ropr

opan

e;

TP

A =

tis

sue

plas

min

ogen

act

ivat

or;

PPL

= p

ars

plan

a le

nsec

tom

y; M

S =

mem

bran

e st

ripp

ing;

PV

R =

pro

life

rati

ve v

itre

oret

inop

athy

; PS

P =

per

isil

icon

e pr

olif

erat

ion;

SB

= s

cler

al b

uckl

e; A

C I

OL

=

ant

erio

r ch

ambe

r in

trao

cula

r le

ns;

EM

UL

SIF

SIO

= e

mul

sifi

catio

n of

sili

cone

oil;

LP

= li

ght

perc

epti

on;

CF

= c

ount

ing

fing

ers.

Kreiger and Lewis' Management of Giant Retinal Tears

that an irregular eye wall surface might distort the retina lying on the posterior surface of a buckle, create gaping of retinal tissue, and foster recurrence of the detachment. Therefore, authors vary in their opinions regarding whether a scleral buckle is necessary in the management of giant retinal tears without PVR. Most surgeons agree, however, that the presence of PVR preoperatively is an indication for scleral buckling as a part of the repair. 1,3,4,13

This pilot study was done to test the hypothesis that in retinal detachment from giant retinal tears with no PVR, excellent anatomic reapposition of the giant retinal tears facilitated by the intraoperative use of perfluorocar­bon liquids, along with meticulous removal of the vitreous in the region of the vitreous base is sufficient to perma­nently repair the retinal detachment, without the need for scleral buckling.

Subjects and Methods

Table 1 summarizes the clinical details of the 11 eyes included in this study. Entry criteria were: retinal detach­ment from a giant retinal tear (tear greater than 90 0 with a posteriorly inverted flap), no evidence of PVR, and in­formed consent. Other patients seen during the same time interval with giant retinal tears and PVR were managed with conventional techniques including scleral buckling. Follow-up ranges from 7 to 29 months (average, 13 months).

Three patients had no previous eye disease, but two of these had prior cataract extraction with posterior chamber intraocular lens implantation. Three patients had a history of trauma (1 penetrating, 2 blunt). There were 6 myopic eyes (3 had vitreous liquefaction, 2 were classified as highly myopic-greater than 10.00 diopters).

Three patients were seen shortly after an attempt to repair the giant retinal tear had failed. The size of the retinal tears varied from 1100 to 3600

• Radial extensions of the tears were noted in 3 eyes, and 1 eye contained 2 separate giant retinal tears (patient 1).

The initial surgical procedure or the reoperation in those three patients referred for reoperation was done without delay in all cases, under general anesthesia. Long­term tamponade was accomplished with intraocular per­fluoropropane in six eyes and with silicone oil in five eyes. Indications for the use of silicone were young age (inability to maintain postoperative positioning) in three eyes, in­traoperative posterior slipping of the giant retinal tear after perfluorocarbon liquid-air exchange in one eye, and pa­tient preference in another eye. In four of five eyes, the silicone oil has been removed.

Operative Procedure

A standard three-port vitrectomy was performed in all cases. The lens was removed by ultrasonic fragmentation in five of six phakic eyes. The lens capsule was completely removed, as has been previously described. 14 In the four

eyes with previous cataract surgery and pseudophakos, the intraocular lens was left in place.

The posterior vitreous detachment was identified, and the vitreous was removed out to the vitreous base. A spe­cial effort was made to trim the residual base down as close to the retina as possible. This was accomplished by deep scleral indentation as shown in Figure 1. The anterior vitreous behind the intraocular lens was removed metic­ulously in pseudophakic eyes. The anterior retinal flap of the giant retinal tear was resected up to the ora serrata. In eyes undergoing lensectomy, the anterior hyaloid was identified and removed back to its origin at the anterior vitreous base.

Injection of perfluoro-octane as has been described by Chang et af was performed to flatten the posterior retina first and then to unroll and flatten the flap of the giant tear (Fig 2). Simultaneously, subretinal fluid was removed with aspiration through a soft-tipped cannula. Once the tear was completely flat and the subretinal fluid was re­moved, endophotocoagulation was applied to the anterior and posterior edges of the tear and to the basal retina for 3600 (Fig 3). Either perfluoropropane or silicone oil was exchanged for the perfluoro-octane. In most of the silicone oil cases, a silicone oil-perfluorocarbon liquid exchange was performed. In one eye, a perfluorocarbon liquid-air exchange was performed followed by an air-silicone oil exchange.

Results

When last examined, all of the retinas were attached (Ta­ble 1). One of the 11 eyes (patient 5) developed recurrence

Figure 1. The basal vitreous gel is removed using deep scleral depression. The anterior retinal flap of the giant retinal tear is resected up to the ora serrata.

493

Ophthalmology Volume 99, Number 4, April 1992

A

c

of the retinal detachment from PVR, which required 2 further operations to repair.

Nine of 11 eyes needed additional surgery (Table 1). Two eyes had a gas-fluid exchange to maintain the intra­ocular bubble at an appropriate size. One of these patients needed cataract surgery 16 months later. Three eyes, all with very large tears, had severe enough fibrin reaction in the anterior chamber to indicate injection of tissue plasminogen activator. Of these three eyes, two with in­traocular gas had gas-fluid exchanges at the same time. Removal of silicone oil was performed in four eyes. Three of the four had removal of peri silicone proliferation at the same timeY In one eye, the silicone oil has been left in place because of postoperative hypotony.

Two eyes, both with 3600 giant retinal tears, developed

494

Figure 2. After vitrectorny, the retina is reattached (A,S) and the giant tear closed securely (C) with intraocular in­jection of perfluro-octane and simultaneous internal drainage of the subretinal fluid.

postoperative hypotony. One developed PVR and re­quired repeat vitrectomy and membrane stripping on two occasions. This eye now has retinal reattachment, but the intraocular pressure is low and the visual prognosis is guarded. Another eye had removal of perisilicone prolif­eration and epiciliary scar tissue at the time of silicone oil removal. Despite retinal reattachment, the intraocular pressure is low.

A macular pucker developed postoperatively in 1 eye (patient 4). This was removed successfully 7 months after surgery; however, the visual acuity returned only to 20/200.

Visual acuity improved in 8 of the 11 eyes. In 2 there was no change, and in 1 the visual acuity dropped from 20/60 preoperatively to 20/100 after cataract extraction

Kreiger and Lewis . Management of Giant Retinal Tears

Figure 3. After the tear is completely flat and the subretinal fluid is removed, endophotocoagulation is applied to the edges of the tear, in­cluding the posterior pars plana. This is continued to include the basal retina for 360° (not shown).

16 months later. In general, however, the final visual acu­ity depended in large measure on whether the macula was detached preoperatively.

Discussion

Although the series is small and the follow-up is limited, the results would tend to support the view that a scleral buckle is not uniformly needed in all cases of giant retinal tears without PVR if one maximally removes the anterior vitreous in the vitreous base and uses perfluorocarbon liquid to insure complete reattachment of the retina and excellent reapposition of the edge of the tear intraopera­tively. In only 1 of the 11 eyes was a recurrent detachment noted and this was from posterior PVR that reopened the 360 0 giant retinal tear. It was judged that a scleral buckle would not have prevented this redetachment in any case. In this eye, two further vitrectomies with membrane re­moval (without a scleral buckle) reattached the retina. Unfortunately, hypotony occurred and the visual prog­nosis is guarded. It is doubtful that a scleral buckle in this eye, or in the eye of patient 6, which also developed hy­potony, would have altered the course or prevented the low pressure. Both eyes in which hypotony developed oc­curred in 3600 giant tears in children. It is our experience that most cases of hypotony are the result of epiciliary scarring, and it is likely that this was the cause in these two cases rather than some other effect of the surgical procedure.

It should be emphasized that, in this study, a special effort was made to remove as much vitreous as possible and to trim the vitreous base as close to the retina and

pars plana as could be done safely.16 Most vitrectomies do not require such radical removal of tissue, so the tech­nique to do this is not widely used. We believe, however, that the main justification for not using a scleral buckle is the reduction of the risk of subsequent traction within the vitreous base internally so that an external buckle is redundant.

To accomplish maximum removal of the vitreous base, there must be excellent pupillary dilation and good illu­mination of the surgical field. Exposure of the anterior retina and ciliary body is only possible if deep scleral depression is done. This can be achieved by the assistant while the surgeon holds the active instrument and the light pipe, or the surgeon can depress the sclera externally with one hand while using the cutting device in the eye with the other. In the latter scenario, the illumination is provided by the assistant, who holds the light pipe over the cornea or the corneal contact lens (Fig 4). The infusion cannula may hinder depression with a scleral depressor or cotton applicator, however indentation of the cannula itself by grasping the hub with a forceps may provide good exposure of the meridian where it is located.

Trauma to the lens is very likely when working in the anterior vitreous. To remove basal vitreous gel, a lensec­tomy must be performed in most phakic eyes and is clearly a disadvantage of this technique. Certainly, preservation of the crystalline lens permits more physiologic postop­erative rehabilitation. In this series, five of six phakic eyes required lensectomy to adequately accomplish the surgical goals. In one case, the surgeon judged that the vitreous could be removed adequately without lensectomy. In this patient, a cataract later developed, which was removed. The presence of a pseudophakos makes the anterior dis­section more difficult and it is often necessary to widen the posterior capsulotomy in order to see. One patient needed iris sutures to provide sufficient pupillary dilation.

The use of perfluoro-octane was essential to flatten the retina and the giant retinal tear completely intraopera­tively.2 Because of the absence of PVR or retinal short­ening in these selected cases, the technique eliminated the subretinal fluid, provided excellent reapposition of the tear, and allowed for endophotocoagulation in all eyes. We believe that this intraoperative secure reattachment of the retina and closure of the tear are as important as radical removal of the anterior vitreous in justifying not performing a scleral buckle. Also, the use of perfluoro­carbon liquid facilitates retinal reattachment without ma­nipulation of the posterior retinal flap and edge of the giant retinal tear, thus decreasing the risk of iatrogenic retinal breaks, hemorrhage, and retinal trauma, all of which contribute to PVR formation.

It is logical that intraocular tamponade is needed until the chorioretinal adhesions are sufficiently strong. Intra­ocular perfluoropropane was used in six eyes. Silicone oil was used in five eyes. The justification for its use was the young age and inability to reliably maintain postoperative positioning in three patients, intraoperative retinal slipping in one eye, and patient preference in one eye. Because of the small numbers, it is not warranted to speculate re­garding the effectiveness of silicone oil versus gas. It is

495

Ophthalmology Volume 99, Number 4, April 1992

A

B

c Figure 4. Deep scleral depression and exposure of the basal vitreous and retina can be accomplished by the assistant while the surgeon holds the active instrument and the light pipe (A), or the surgeon can depress the sclera externally with one hand while using the cutting device in the eye with the other. In the latter scenario, the illumination is provided by the assistant, who holds the light pipe over the cornea (B) or over the corneal contact lens (C). For simplicity, the infusion cannula is not shown.

496

clear, however, that silicone oil may be associated with perisilicone proliferation 15 as this was noted in three of four patients in which the oil was removed. Furthermore, removal of silicone is another major intervention with inherent surgical risks. In one patient, emulsification of the oil was so severe that it had to be removed 6 weeks after surgery. In one patient, the silicone oil was left in place because hypotony had developed in the eye. No perisilicone proliferation is present in this eye.

Additional surgery was done in 9 of 11 eyes. Because some eyes required more than 1 procedure, a total of 13 procedures were performed. Eight operations were major: removal of silicone oil in four (with removal of perisilicone proliferation in three), repeat vitrectomy and membrane removal with endophotocoagulation twice in one eye, cataract extraction in one eye, and macular pucker re­moval in one eye. Five operations were minor: gas-fluid exchange in two eyes, t-PA injection with gas-fluid ex­change in two eyes, and t-PA injection in one eye. We believe that these operations were unrelated to the pres­ence or absence of a scleral buckle.

We recognize that not using a scleral buckle has po­tential disadvantages. One certainly sacrifices the security of long-term mechanical support of the vitreous base. Ideally, a randomized clinical trial to test the necessity of scleral buckling should be performed to answer this ques­tion decisively. This may not be practical, however, be­cause of the great variability of giant retinal tears and the small number of cases that occur. In the interim, it seems reasonable to consider not performing a scleral buckle procedure in those cases where there is no PVR or anterior retinal pathology, where the anterior vitreous can be care­fully removed (pseudophakia, aphakia, lensectomy), and where the retina can be totally reattached intraoperatively using such techniques as perfluorocarbon liquid manip­ulation.

References

1. Michels RG, Wilkinson CP, Rice TA. Retinal Detachment. St. Louis: CV Mosby, 1990;638-69.

2. Chang S, LincoffH, Zimmerman NJ, Fuchs W. Giant retinal tears. Surgical techniques and results using perfluorocarbon liquids. Arch Ophthalmol 1989; 107:761-6.

3. Cairns JD, Campbell WG. Vitrectomy techniques in the treatment of giant retinal tears: a flexible approach. Aust N Z J Ophthalmol 1988;16:209-14.

4. Freeman HM. Current management of giant retinal breaks and fellow eyes. In: Ryan SJ, ed. Retina. Vol. 3: Surgical Retina. St. Louis: CV Mosby, 1989;431-48.

5. Holland PM, Smith TR. Broad scleral buckle in the man­agement of retinal detachments with giant tears. Am J Ophthalmol 1977;83:518-25.

6. Holland PM. The Taylor Smith approach to giant tears. Retina 1983;3:293-5.

7. Freeman HM, Castillejos ME. Current management of giant retinal breaks: results with vitrectomy and total air fluid exchange in 95 cases. Trans Am Ophthalmol Soc 1981;79: 89-102.

Kreiger and Lewis . Management of Giant Retinal Tears

8. Michels RG, Rice TA, Blankenship G. Surgical techniques for selected giant retinal tears. Retina 1983;3: 139-53.

9. Vidaurri-Leal J, de Bustros S, Michels RG. Surgical treat­ment of giant retinal tears with inverted posterior retinal flaps. Am J Ophthalmol 1984;98:463-6.

10. Lewis JS, McCuen BW II, Tiedeman JS, Awan KJ. Current views on giant retinal tears. Pak J OphthalmoI1985;1:215-21.

11. Hoffman ME, Sorr EM. Management of giant retinal tears without scleral buckling. Retina 1986;6: 197-204.

12. Leaver PK, Billington BM. Vitrectomy and fluid/silicone­oil exchange for giant retinal tears: 5 years follow-up. Graefes Arch Clin Exp Ophthalmol 1989;227:323-7.

13. Glaser BM. Treatment of giant retinal tears combined with proliferative vitreoretinopathy. Ophthalmology 1986;93: 1193-7.

14. Lewis H, Aaberg TM, Abrams GW, et al. Management of the lens capsule during pars plana lensectomy [letter]. Am J Ophthalmol 1987;103:109-10.

15. Lewis H, Burke JM, Abrams GW, Aaberg TA. Perisilicone proliferation after vitrectomy for proliferative vitreoreti­nopathy. Ophthalmology 1988;95:583-91.

16. Lewis H, Aaberg TA, Abrams GW. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreo­retinopathy. Am J Ophthalmol 1991; III :8-14.

Discussion by

BrooksVV.~cCuenII,~

Drs. Kreiger and Lewis present a series of II patients with uncomplicated giant retinal tears treated by vitrectomy, radical dissection of the vitreous base, fluid-perfluorocarbon liquid ex­change, endophotocoagulation, and no scleral buckle. Six eyes received perfluoropropane gas and 5 eyes received silicone oil. They achieved ultimate retinal reattachment with a minimum of7 months follow-up in all II of the operated eyes, with vision improving in 8 eyes.

There have been several previous reports of the treatment of giant retinal tears without scleral buckling, also with good results. In 1986 Hoffman and Sorr1 reported success in 6 of 6 patients using vitrectomy and an expanding gas bubble technique. In 1987, Kreissig and associates2 reported success in 4 of 5 eyes using a modified pneumatic retinopexy technique without either vitrectomy or scleral buckling. In 1989 Chang and associates3

reattached 7 of 7 eyes using vitrectomy and liquid perfluoro­carbon exchange without scleral buckling. At this year's Retina Society meeting, Freeman presented his series of20 giant retinal tears that he treated in a manner very similar to Kreiger and Lewis, including vitrectomy, lensectomy, radical dissection of the vitreous base, and liquid perfluorocarbon injection without the use of a scleral buckle (Freeman, unpublished data). Freeman used intraocular gas in all cases and was successful in reattaching 16 (80%) of these eyes.

The results in the series by Kreiger and Lewis are impressive, but as the authors correctly point out, there are some other factors to consider. To adequately dissect the vitreous base, the crys­talline lens had to be removed in 5 of the 6 eyes that were phakic preoperatively. Conventional vitreous surgery with the use of a scleral buckle to support the region of the vitreous base, rather than the radical dissection ofthe base advocated by the authors, allows the retention of the crystalline lens in selected cases. Leaving the lens in place at the time of the primary vitrectomy allows for conventional cataract surgery and posterior chamber intraocular lens implantation, should later cataract develop.

While the anatomic retinal reattachment rate is excellent in this series, more than a single operative procedure was required

From the Duke University Eye Center, Durham.

in 9 of the II eyes (82%). Excluding postoperative fluid-gas exchange and tissue plasminogen activator injection, both of which the authors considered minor, 8 ofthe 13 total secondary procedures performed were considered major. As found in this series, other reports of giant retinal tear surgery without scleral buckling document a frequent necessity for reoperation. 1

-3 But

would the addition of a scleral buckle reduce the need for re­operations in eyes with giant retinal tears? The difficulty in an­swering this question stems from a lack of adequate controls, thus making a critical interpretation of the authors' findings im­possible. For this reason, I would suggest caution in concluding that scleral buckles are not indicated in uncomplicated giant retinal tear surgery.

In summary, Drs. Kreiger and Lewis have presented an in­creasingly popular technique for the management of selected giant retinal tears in which vitrectomy is combined with the use of perfluorocarbon liquids, vitreous base surgery, extended in­traocular tamponade, and omission of a scleral buckle. Their ultimate anatomic and visual results are excellent, but intra­operative lensectomy in phakic eyes is usually required, and multiple operative procedures are frequently necessary to achieve these results. As they correctly point out, this series is small, uncontrolled, and has limited long-term follow-up. Whether the addition of an intraoperative scleral buckle would reduce the necessity for lensectomy or the need for additional surgical pro­cedures is not possible to determine in the absence of an adequate control group.

References

1. Hoffman ME, Sorr EM. Manageplent of giant retinal tears without scleral buckling. Retina 1986;6: 197 -204.

2. Kreissig I, Lincoff H, Stanowsky A. The treatment of giant tear detachments using retrohyaloidal perfluorocarbon gases without drainage or vitrectomy. Graefes Arch Clin Exp Ophthalmol 1987;225:94-8.

3. Chang S, LincoffH, Zimmerman NJ, Fuchs W. Giant retinal tears: surgical techniques and results using perfluorocarbon liquids. Arch Ophthalmol 1989; 1 07:761-6.

497